Using β-lactam/β-lactamase inhibitors for infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae to slow the emergence of carbapenem-resistant Enterobacteriaceae-Reference-Cited by-同舟云学术

Using β-lactam/β-lactamase inhibitors for infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae to slow the emergence of carbapenem-resistant Enterobacteriaceae

Published:2017-09-21 Issue:10 Volume:15 Page:893-895
ISSN:1478-7210
Container-title:Expert Review of Anti-infective Therapy
language:en
Short-container-title:Expert Review of Anti-infective Therapy

Author:

Watkins Richard R.¹²,Deresinski Stan³

Affiliation:

1. Department of Internal Medicine, Northeast Ohio Medical University, Rootstown, OH, USA

2. Division of Infectious Diseases, Cleveland Clinic Akron General, Akron, OH, USA

3. Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, CA, USA

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Microbiology (medical),Microbiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14787210.2017.1380519

Reference23 articles.

1. Vital Signs: Preventing Antibiotic-Resistant Infections in Hospitals — United States, 2014

2. Clinical and Economic Impact of Bacteremia with Extended- Spectrum-β-Lactamase-Producing Enterobacteriaceae

3. Predictors of Mortality in Patients with Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae : Importance of Inadequate Initial Antimicrobial Treatment

4. Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs)

5. Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review of recent advances in the treatment of adults with complicated urinary tract infection;Expert Review of Clinical Pharmacology;2022-09-02

2. Comparison of the Effectiveness of Piperacillin-Tazobactam and Carbapenems in Nosocomial Infections with Extended-Spectrum Beta-lactamase-Producing Escherichia coli and Klebsiella pneumoniae;Mediterranean Journal of Infection Microbes and Antimicrobials;2020-07-21

3. Current trends in the treatment of pneumonia due to multidrug-resistant Gram-negative bacteria;F1000Research;2019-02-06

4. Current trends in the treatment of pneumonia due to multidrug-resistant Gram-negative bacteria;F1000Research;2019-01-30

5. Ceftolozane/tazobactam: place in therapy;Expert Review of Anti-infective Therapy;2018-03-09